Amiloride Hydrochloride and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Amiloride Hydrochloride and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | amiloride hydrochloride and hydrochlorothiazide |
| SUBSTANCE NAME: | AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1991-10-31 |
| END MARKETING DATE: | 0000-00-00 |
Amiloride Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amiloride Hydrochloride and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 50(mg/1; mg/1) |
| START MARKETING DATE: | 1991-10-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-0577_bc568ed8-6312-4d66-9ea5-80ca9424343e |
| PRODUCT NDC: | 0378-0577 |
| APPLICATION NUMBER: | ANDA073209 |
Other AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
